114 related articles for article (PubMed ID: 37622223)
1. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case-control study.
Şenel E; Salmanoğlu M; Solmazgül E; İnal BB
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1811-1814. PubMed ID: 37622223
[TBL] [Abstract][Full Text] [Related]
2. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: a case-control study.
Senel E; Salmanoğlu M; Solmazgül E; Berçik İnal B
J Eur Acad Dermatol Venereol; 2011 Dec; ():. PubMed ID: 22188364
[TBL] [Abstract][Full Text] [Related]
3. Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study.
Shah R; Jindal A; Patel N
Ann Med Health Sci Res; 2014 Mar; 4(2):202-5. PubMed ID: 24761238
[TBL] [Abstract][Full Text] [Related]
4. Association between acrochordons and the components of metabolic syndrome.
Akpinar F; Dervis E
Eur J Dermatol; 2012; 22(1):106-10. PubMed ID: 22063265
[TBL] [Abstract][Full Text] [Related]
5. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study.
Rasi A; Soltani-Arabshahi R; Shahbazi N
Int J Dermatol; 2007 Nov; 46(11):1155-9. PubMed ID: 17988334
[TBL] [Abstract][Full Text] [Related]
6. Acrochordon and impaired carbohydrate metabolism.
Demir S; Demir Y
Acta Diabetol; 2002 Jun; 39(2):57-9. PubMed ID: 12120914
[TBL] [Abstract][Full Text] [Related]
7. Supplementation of Syzygium cumini seed powder prevented obesity, glucose intolerance, hyperlipidemia and oxidative stress in high carbohydrate high fat diet induced obese rats.
Ulla A; Alam MA; Sikder B; Sumi FA; Rahman MM; Habib ZF; Mohammed MK; Subhan N; Hossain H; Reza HM
BMC Complement Altern Med; 2017 Jun; 17(1):289. PubMed ID: 28578702
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
9. Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg/dL in Taiwanese population.
Hsiao JY; Wang CL; Hsia PJ; Hsieh MC; Hsin SC; Lin KD; Shin SJ
Pancreas; 2007 Nov; 35(4):343-7. PubMed ID: 18090240
[TBL] [Abstract][Full Text] [Related]
10. Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension.
Shionoiri H; Takasaki I; Naruse M; Nagamoti I; Himeno H; Ito T; Ohtomi S; Hata T; Shindo K; Mikami H
Clin Ther; 1995; 17(6):1126-35. PubMed ID: 8750404
[TBL] [Abstract][Full Text] [Related]
11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.
Sheu WH; Jeng CY; Young MS; Le WJ; Chen YT
Am J Med Sci; 2000 Feb; 319(2):84-8. PubMed ID: 10698091
[TBL] [Abstract][Full Text] [Related]
14. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study.
Matrozova J; Steichen O; Amar L; Zacharieva S; Jeunemaitre X; Plouin PF
Hypertension; 2009 Apr; 53(4):605-10. PubMed ID: 19221213
[TBL] [Abstract][Full Text] [Related]
15. Lipid Abnormalities in Patients With Cushing's Disease and Its Relationship With Impaired Glucose Metabolism.
Sun X; Feng M; Lu L; Zhao Z; Bao X; Deng K; Yao Y; Zhu H; Wang R
Front Endocrinol (Lausanne); 2020; 11():600323. PubMed ID: 33633684
[TBL] [Abstract][Full Text] [Related]
16. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
Umpaichitra V; Banerji MA; Castells S
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
[TBL] [Abstract][Full Text] [Related]
17. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
[TBL] [Abstract][Full Text] [Related]
18. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Felodipine Multicenter Prospective Study Group in Japan.
Shionoiri H; Takizawa T; Ohyama Y; Ishii J; Katayama S; Nagasawa T; Kitamoto K; Nagasawa K; Hariya Y; Sato R
Hypertension; 1994 Jan; 23(1 Suppl):I215-9. PubMed ID: 8282362
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte telomere length is inversely associated with post-load but not with fasting plasma glucose levels.
Khalangot M; Krasnienkov D; Vaiserman A; Avilov I; Kovtun V; Okhrimenko N; Koliada A; Kravchenko V
Exp Biol Med (Maywood); 2017 Apr; 242(7):700-708. PubMed ID: 28299976
[TBL] [Abstract][Full Text] [Related]
20. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
